0001567619-22-013208.txt : 20220621 0001567619-22-013208.hdr.sgml : 20220621 20220621182711 ACCESSION NUMBER: 0001567619-22-013208 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220616 FILED AS OF DATE: 20220621 DATE AS OF CHANGE: 20220621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TREACE JAMES T CENTRAL INDEX KEY: 0001185191 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40355 FILM NUMBER: 221029417 MAIL ADDRESS: STREET 1: 117 BRISTOL PLACE CITY: PONTE VEDRA BEACH STATE: FL ZIP: 32082 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC. CENTRAL INDEX KEY: 0001630627 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 471052611 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 203 FORT WADE ROAD STREET 2: SUITE 150 CITY: PONTE VEDRA STATE: FL ZIP: 32081 BUSINESS PHONE: (904) 373-5940 MAIL ADDRESS: STREET 1: 203 FORT WADE ROAD STREET 2: SUITE 150 CITY: PONTE VEDRA STATE: FL ZIP: 32081 4 1 doc1.xml FORM 4 X0306 4 2022-06-16 0 0001630627 TREACE MEDICAL CONCEPTS, INC. TMCI 0001185191 TREACE JAMES T C/O TREACE MEDICAL CONCEPTS, INC. 203 FORT WADE ROAD, SUITE 150 PONTE VEDRA FL 32081 1 0 0 0 Common Stock 2022-06-16 4 S 0 20809 13.5794 D 1315632 D Common Stock 2022-06-17 4 S 0 29191 13.734 D 1286441 D Common Stock 556183 I By spouse Transactions made pursuant to a 10b5-1 trading plan adopted by the Reporting Person. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.33 to $14.04 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $13.52 to $14.00 inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Lisa Taylor, as Attorney-in-fact for James T. Treace 2022-06-21